Boiron’s Arnicare Gel available as homeopathic pain reliever
NEWTOWN SQUARE, Pa. Boiron is pitching its homeopathic pain reliever Arnicare Gel to Americans on the go, the company announced last week.
“Individuals unaccustomed to tasks such as gardening or home improvement and fitness buffs and athletes who want to maintain their active lifestyles will find that Arnicare Gel is one of the safest options for self-treatment,” stated Christophe, Merville, Boiron’s pharmaceutical development manager. “Applying a thin layer of the gel on the affected area soon after an injury occurs can provide adequate relief of muscle aches, stiffness and bruising. Persons of all ages can recover more quickly no matter what the activity.”
The active ingredient in Arnicare Gel is Arnica montana, the company stated, also known as the Mountain daisy, a perennial plant commonly found in the Northwestern parts of the U.S. and Central Europe.
Arnicare Gel is available in a small 2.6 oz. tube.
DSIB, CRN join others in opposing weight-loss claim petition
SARASOTA, Fla. The Dietary Supplement Information Bureau, comprised of the American Herbal Products Association, New Hope (event organizer for NatExpo East and West) and the Natural Products Association, on Monday joined the Council for Responsible Nutrition in pledging to fight against a recently-filed citizen’s petition that would render weight-loss claims as disease state claims, a classification that would prohibit dietary supplement manufacturers from making any before-and-after weight loss claims in support of a dietary supplement diet aid.
The petition was jointly filed April 17 by GlaxoSmithKline, the American Dietetic Association, Shaping America’s Health and the Obesity Society.
In a blog posted Monday afternoon, the Bureau charged, “Many believe that this is an effort by GlaxoSmithKline, makers of alli, an over-the-counter weight loss drug, to quash competition from the dietary supplement weight loss industry. … GlaxoSmithKline’s petition has huge implications for dietary supplements, and we feel that a negative ruling by the FDA could result in more attacks from pharmaceutical companies, and perhaps eventually the death knell for the dietary supplements industry.”
Oragenics announces test marketing of Probiora3 probiotic
ALACHUA, Fla. Oragenics last week announced the test marketing of its oral probiotic product, Probiora3. The chewable tablets help to whiten teeth and improve breath though the use of a unique combination of safe, naturally occurring bacteria that are released in the mouth by chewing on a mint-flavored tablet twice daily.
“I am enthusiastic about the current and potential consumer benefits of Probiora3, and recognize that it marks the first of what we hope are a long line of pharma and non-pharma products to reach market in time to come,” stated Rick Welch, Oragenics chairman.
The company expects to begin direct-to-consumer sales within the next month through a subsidiary company and to bring the product to the public’s attention through the media.